{"transactions":[{"id":3689141,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T21:18:40.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":145000,"derivative":{"exercise_price":2.64,"expiration_date":"2029-01-17","underlying":"Common Stock, $0.001 par value","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001171843-19-000436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319000436/ownership.xml","form_type":"4"}},{"id":3707807,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Common Stock","published_at":"2019-01-03T13:19:32.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":2448,"price":1.93,"value":4724.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":29132,"source":{"system":"sec-edgar","filing":"0001171843-19-000064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319000064/ownership.xml","form_type":"4"}},{"id":3874248,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Common Stock","published_at":"2018-07-03T12:19:58.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":10000,"price":1.615,"value":16150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":26684,"source":{"system":"sec-edgar","filing":"0001171843-18-004989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318004989/ownership.xml","form_type":"4"}},{"id":4095794,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T22:16:50.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":200000,"derivative":{"exercise_price":2.85,"expiration_date":"2028-01-16","underlying":"Common Stock, $0.001 par value","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001171843-18-000441","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318000441/formfour.xml","form_type":"4"}},{"id":4110762,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Common Stock","published_at":"2018-01-03T13:16:19.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":3934,"price":1.296,"value":5098.464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":16684,"source":{"system":"sec-edgar","filing":"0001171843-18-000082","document":"form4eldridge.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318000082/form4eldridge.xml","form_type":"4"}},{"id":4163399,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Common Stock","published_at":"2017-11-14T22:05:38.000Z","date":"2017-11-14","kind":"purchase","acquired":true,"shares":295,"price":1.69,"value":498.55,"ownership":{"direct":false,"nature":"As custodian for child's UTMA account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":1545,"source":{"system":"sec-edgar","filing":"0001171843-17-007021","document":"f4_111417eldridge.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007021/f4_111417eldridge.xml","form_type":"4"}},{"id":4263514,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, CFO, Treasr, Asst Secy"}}],"security":"Common Stock","published_at":"2017-07-05T20:11:00.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":10000,"price":1.296,"value":12960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":12750,"source":{"system":"sec-edgar","filing":"0001171843-17-003952","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317003952/formfour.xml","form_type":"4"}},{"id":4480353,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160917,"kind":"person","name":"Eldridge, George Arthur","position":1,"cik":"0001622905","reported_name":"Eldridge, George Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Snr VP,CFO,Treasurer,Asst Secy"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-26T13:00:53.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":53119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 24, 2017 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":53119,"derivative":{"exercise_price":2.05,"expiration_date":"2027-01-23","underlying":"Common Stock, $0.001 par value","underlying_shares":53119},"source":{"system":"sec-edgar","filing":"0001171843-17-000452","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317000452/formfour.xml","form_type":"4"}}]}